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Preface
Regulation of tRNA synthesis and modiﬁcation in physiological conditions
and disease
Transfer RNAs (tRNAs) are essential adaptor molecules that convert
information contained in mRNA into amino acid sequence. How tRNAs
read the genetic code was ﬁrst proposed by Francis Crick in 1958. tRNA
biogenesis, a central pathway essential to all living organisms, has been
a subject of interest from the dawn of molecular biology until present-
day. tRNA biogenesis involves multiple steps, including synthesis of the
initial transcript, maturation of tRNA precursors and charging of tRNA
molecules with amino acids. Given the critical role of tRNAs in trans-
lation, it is not surprising that cells devote signiﬁcant resources to tRNA
production. Protein complexes involved in tRNA biogenesis have been
identiﬁed by both genetic and biochemical approaches, which were
followed by structural analysis. tRNA maturation and charging occur
both in the nucleus and in the cytoplasm, this necessitated that the ﬁeld
explore the cell biology behind tRNA production. This special issue will
take us through the tRNA biosynthesis process, with a special emphasis
on the regulation of tRNA production by cellular cues.
Process of tRNA synthesis is highly eﬃcient, leading to the pro-
duction of 3 million tRNAs per generation in the model organism
budding yeast, compare that number to the ~60,000 mRNAs, and one
can appreciate the resources committed to produce tRNAs. Because of
the energy devoted to tRNA production and because of the required
coordination of tRNA and ribosome function, the regulation of tRNA
biosynthesis in response to various forms of environmental stress is
beneﬁcial for cell economy. For unicellular eukaryotes such as yeast,
this process is important for optimal utilization of nutrients and sur-
vival. For higher eukaryotes, tRNA production is linked to changes in
cell proliferation and cell cycle control. Dysregulation of tRNA bio-
synthesis leads to a number of pathological states, including cancer.
Within the past two decades, there has been much progress in deci-
phering the multiple layers of control in each step of tRNA biogenesis.
In this special issue of BBA-GRM, entitled “Regulation of tRNA synthesis
and modiﬁcations”, 15 review articles from some of the world's leading
experts bring together many ideas that drive home the point that the
levels of functional tRNAs, which commonly been regarded as abundant
“house-keeping” RNAs, are indeed highly regulated.
The special issue opens with a comprehensive overview by Ewan
Ramsay and Alessandro Vannini, who cover the dynamic structure of
Pol III machinery. This review summarizes the biochemical and struc-
tural data on the plasticity of Pol III and its auxiliary factors, TFIIIB and
THIIIC, which accounts for regulation each step of tRNA transcription.
The rapid transition from repression to activation of tRNA genes is
maintained by the epigenetic state of the genes, controlled by chro-
matin modiﬁers. Ashutosh Shukla and Purnima Bhargava describe the
role of chromatin structure and nucleosome dynamics in the budding
yeast in tRNA transcription. Because they were once thought to be
“nucleosome free”, the chromatin context of tRNAs genes has received
relatively little attention until now.
The control of tRNA synthesis by signaling pathways is achieved by
direct targeting of the Pol III complex through phosphorylation and
sumoylation of Pol III subunits. The review by Pierre Chymkowitz and
Jorrit M. Enserink summarize the relevance of post-translational mod-
iﬁcations of Pol III subunits for regulation of tRNA synthesis. Key tar-
gets of signaling pathways include the initiation factors, TFIIIB and
TFIIIC, and the transcriptional repressor Maf1. TFIIIB and TFIIIC are
multi-protein complexes regulated at the level of expression of their
individual subunits, as well as through phosphorylation and interaction
with partner proteins. Particular aspects of this control in yeast and
human cells are described in a review by Damian Graczyk and collea-
gues.
The transcriptional repressor Maf1 inhibits tRNA synthesis under
conditions that are detrimental to cell growth. Ian Willis covers the
relationship between Pol III activity and cell physiology, describing
various Maf1 phenotypes in diﬀerent model organisms and cell based
systems. Furthermore, Steven Zheng provides insights into the role of
Maf1 in growth, aging and oncogenesis, emphasizing the regulation of
Pol III by TOR signaling. Importantly, major components of the Maf1
regulatory network are conserved, as illustrated by Celso Benedetti's
review on the role of Maf1 in repressing Pol III and suppressing cell
growth and proliferation in plants through the TOR pathway.
The ﬁnal article in this section by Aneeshkumar Arimbasseri ana-
lyses interactions between Pol III transcription machinery and tRNA
processing factors. In contrast to Pol II system, there is no direct cou-
pling of Pol III transcription and processing. Instead, tRNA processing
factors “moonlight” in Pol III transcription and transcription levels in-
directly aﬀects tRNA modiﬁcation machinery.
The second part of this special issue includes articles that address
how environmental stresses and cell status can aﬀect the maturation of
tRNA precursors and tRNA modiﬁcations.
Early steps in tRNA maturation require the chaperone-like La pro-
tein, which helps prevent pre-tRNA misfolding and mischanneling into
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oﬄine pathways. The current knowledge on La function and regulation
is summarized in the review by Nathan Blewett and Richard Maraia.
This article gives unique perspective on diﬀerences between yeast and
mammals in the subcellular partitioning of pre-tRNA intermediates and
diﬀerential interactions with La.
tRNA transcription and numerous processing steps occurring in the
nucleus are followed by tRNA export to the cytoplasm. The nuclear-
cytoplasmic traﬃc of tRNAs is, however, not unidirectional; because
tRNA may be also imported back to the nucleus. This tRNA retrograde
nuclear import is conserved from budding yeast to vertebrate cells and
is stimulated upon nutrient deprivation. A role for intracellular tRNA
dynamics is reviewed by Anita Hopper and colleagues, which includes a
comprehensive overview of the multiple tRNA nuclear export and im-
port pathways. The subcellular partitioning of factors critical for tRNA
function includes the regulation of aminoacyl-tRNA synthetases. The
article by Hubert Becker and colleagues covers the subcellular com-
partments that aminoacyl-tRNA synthetases can occupy in bacteria and
eukaryotes, as well as the mechanisms and the signaling pathways that
trigger their relocation. Since aminoacyl-tRNA synthetases participate
to a wide range of cellular pathways beyond translation, but equally
important for cellular homeostasis, the dis-regulation of the subcellular
partitioning is associated with the pathologies and diseases.
tRNA modiﬁcations are subject to regulation as well. Anders
Byström with colleagues review the multistep biosynthesis of wobble
base uridines in eukaryotic tRNAs which requires the conserved six-
subunit Elongator complex. Although Elongator has been implicated in
several diﬀerent cellular processes, accumulating evidence suggests
that its which in turn, controls translational decoding. A complicated
interconnectivity between diﬀerent enzymatic modiﬁcation cascades,
and their resulting tRNA modiﬁcations, are reviewed by Sebastian Glatt
and colleagues. As the lack of speciﬁc modiﬁcations in the anticodon
stem and loop causes disrupted proteome homeostasis, diminished re-
sponse to stress conditions, and the onset of human diseases, the
modiﬁcation cascades have recently gained basic science and clinical
interest. Since expression of several microbial virulence factors is in-
duced by changes in environmental conditions, proper control of tRNA
modiﬁcations have the multifaceted implications for infection and pa-
thogenicity and is important determinant for maintaining cellular
function and viability during stress. Regulation of the tRNA
modiﬁcation levels in response to physiological stresses is discussed by
Cha San Koh and Peter Sarin. Future development of novel methods and
combinatory utilization of existing technologies will bring tRNA mod-
iﬁcation-mediated regulation of cellular immunity and pathogenicity to
the limelight.
Numerous diseases are linked to defective tRNA molecules, which
are normally continuously scrutinized and eliminated from cells. Mario
Morl and colleagues review recent discoveries that the enzyme re-
sponsible for the de novo synthesis of the CCA triplet into the 3′end of
tRNAs plays an indispensable role in tRNA quality control by in-
corporating a second CCA triplet into hypomodiﬁed, unstable tRNAs
that is recognized as a degradation tag. This ﬁnal review, gives an
update on the latest ﬁndings regarding tRNA quality control that turns
out to represent an interplay of the CCA-adding enzyme and RNases
involved in tRNA degradation and maturation.
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